Invention Grant
US08455626B2 Aβ conformer selective anti-aβ globulomer monoclonal antibodies
有权
Abeta构象异构抗体选择性抗球蛋白单克隆抗体
- Patent Title: Aβ conformer selective anti-aβ globulomer monoclonal antibodies
- Patent Title (中): Abeta构象异构抗体选择性抗球蛋白单克隆抗体
-
Application No.: US11945124Application Date: 2007-11-26
-
Publication No.: US08455626B2Publication Date: 2013-06-04
- Inventor: Stefan Barghorn , Heinz Hillen , Andreas R. Striebinger , Boris Labkovsky , Ulrich Ebert , Patrick Keller
- Applicant: Stefan Barghorn , Heinz Hillen , Andreas R. Striebinger , Boris Labkovsky , Ulrich Ebert , Patrick Keller
- Applicant Address: US IL Abbott Park
- Assignee: Abbott Laboratories
- Current Assignee: Abbott Laboratories
- Current Assignee Address: US IL Abbott Park
- Agency: Michael Best & Friedrich LLP
- Agent Lisa V. Mueller
- Main IPC: C07K16/18
- IPC: C07K16/18 ; C12P21/08 ; A61K39/395

Abstract:
The subject invention relates to monoclonal antibodies that may be used in the treatment and diagnosis of Alzheimer's Disease. In particular, the present invention relates to monoclonal antibodies referred to as 10F4 and 3C5 and to other monoclonal antibodies (e.g., murine, human or humanized) having similar properties thereto.
Public/Granted literature
- US20090035307A1 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES Public/Granted day:2009-02-05
Information query